Unknown

Dataset Information

0

Antifungal susceptibility profile and local epidemiological cut-off values of Yarrowia (Candida) lipolytica: an emergent and rare opportunistic yeast.


ABSTRACT:

Importance

Yarrowia lipolytica, also known as Candida lipolytica, is an emerging opportunistic "rare pathogenic yeast". Due to the limited data on its antifungal susceptibility, the clinical treatments become challenging. Based on the China Hospital Invasive Fungal Surveillance Network (2009-2022), we conducted a comprehensive multi-method study on clinical isolates from various central hospitals. This study is currently the largest study carried out to assess the antifungal susceptibility of Y. lipolytica. It is also the first to establish local epidemiological cut-off values (L-ECOFFs), identify its ERG11 mutations, and assess the consistency between the three prevalent commercial antifungal susceptibility testing methods and the broth microdilution method. We recommend the Sensititre YeastOne as the best option for antifungal susceptibility testing for Y. lipolytica, followed by the ATB FUNGUS 3. Nevertheless, practitioners should use the MIC test strip with discretion.

SUBMITTER: Yu J 

PROVIDER: S-EPMC10783140 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antifungal susceptibility profile and local epidemiological cut-off values of <i>Yarrowia</i> (<i>Candida</i>) <i>lipolytica</i>: an emergent and rare opportunistic yeast.

Yu Jinhan J   Liu Xueqing X   Guo Dawen D   Yang Wenhang W   Chen Xinfei X   Zou Guiling G   Wang Tong T   Pang Shichao S   Zhang Ge G   Dong Jingjing J   Xu Yingchun Y   Zhao Ying Y  

Microbiology spectrum 20231212 1


<h4>Importance</h4><i>Yarrowia lipolytica</i>, also known as <i>Candida lipolytica</i>, is an emerging opportunistic "rare pathogenic yeast". Due to the limited data on its antifungal susceptibility, the clinical treatments become challenging. Based on the China Hospital Invasive Fungal Surveillance Network (2009-2022), we conducted a comprehensive multi-method study on clinical isolates from various central hospitals. This study is currently the largest study carried out to assess the antifunga  ...[more]

Similar Datasets

| S-EPMC6302869 | biostudies-literature
| S-EPMC4609733 | biostudies-literature
| S-EPMC5841406 | biostudies-literature
| S-EPMC6997362 | biostudies-literature
| S-EPMC11434977 | biostudies-literature
| S-EPMC9299812 | biostudies-literature
| S-EPMC4709189 | biostudies-literature
2011-05-15 | GSE29046 | GEO
| S-EPMC9252082 | biostudies-literature
| S-EPMC2447202 | biostudies-literature